NFSG
BCAB icon

Newbridge Financial Services Group’s BioAtla BCAB Stock Holding History

Newbridge Financial Services Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$58 – 1169
2023
Q3 		$58 Hold
1
– – ﹤0.01% 1257
2023
Q2 		$102 Hold
1
– – ﹤0.01% 1302
2023
Q1 		$91 Hold
1
– – ﹤0.01% 1365
2022
Q4 		$281 Hold
1
– – ﹤0.01% 1379
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1387
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1368
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1443
2021
Q4 		$1K Hold
1
– – ﹤0.01% 1301
2021
Q3 		$1K Hold
1
– – ﹤0.01% 1228
2021
Q2 		$1K Hold
1
– – ﹤0.01% 1331
2021
Q1 		$2K Buy
+1
New +$2.56K ﹤0.01% 1158

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Newbridge Financial Services Group's BCAB Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of BioAtla (BCAB) in Q4 2023, closing a stake of 1 share — an estimated $58 sold.

Newbridge Financial Services Group first reported a position in BCAB in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q1 2021. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining BioAtla position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 1 BioAtla share in Q4 2023, an estimated $58.
  • Newbridge Financial Services Group first reported a position in BioAtla in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's BioAtla position peaked at $2K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held BioAtla as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.